Form 4: Trulieve Cannabis Corp. Executive Granted Stock Options
SEC Form 4 Filing
Joy Malivuk, Chief Accounting Officer of Trulieve Cannabis Corp., was granted stock options exercisable for 72,340 subordinate voting shares.
Summary
- Joy Malivuk, the Chief Accounting Officer of Trulieve Cannabis Corp., received stock options on March 25, 2025.
- The options grant Malivuk the right to purchase 72,340 subordinate voting shares at an exercise price of $4.03 per share.
- The options vest in three equal annual installments starting December 1, 2025, and expire on March 25, 2032.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of stock option grants, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is slightly positive as it indicates investment in key personnel.
Positives
- The granting of stock options to a key executive aligns their interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the Chief Accounting Officer.
Industry Context
Stock option grants are a common practice in the cannabis industry to attract and retain key talent, aligning their interests with the company's long-term performance.
Comparison to Industry Standards
- Comparing Trulieve's executive compensation structure to that of peers like Curaleaf, Green Thumb Industries, and Canopy Growth would provide a benchmark for assessing the competitiveness and appropriateness of the stock option grant.
- Industry standards for vesting schedules typically range from three to five years, with annual or quarterly vesting increments.
- The exercise price is usually set at or above the market price of the stock on the grant date.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the Chief Accounting Officer to contribute to the company's success.
- Employees may see this as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of the stock option grant. |
| 03/25/2025 | Earliest transaction date. |
| 12/01/2025 | First vesting date for one-third of the options. |
| 12/01/2026 | Second vesting date for one-third of the options. |
| 12/01/2027 | Third vesting date for one-third of the options. |
| 03/25/2032 | Expiration date of the stock options. |
| 03/28/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Trulieve Cannabis Corp., executive compensation, Form 4, insider trading, Joy Malivuk, TRUL, Chief Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.